BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:09 PM
Mar 24, 2009
 |  BC Extra  |  Company News

Aveo, Biogen Idec in antibody deal

Aveo (Cambridge, Mass.) and Biogen Idec (NASDAQ:BIIB) partnered to co-develop Aveo's antibodies targeting epidermal growth factor receptor 3...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >